Literature DB >> 15829997

Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.

A Curgunlu1, H Uzun, I Bavunoğlu, Y Karter, H Genç, S Vehid.   

Abstract

Elevated plasma levels of the endogenous nitric oxide (NO) synthase inhibitor asymmetric dimethylarginine (ADMA) contribute to endothelial dysfunction and seem to be a predictor for cardiovascular mortality. Elevated ADMA plasma concentrations have been demonstrated in patients with hypertension. However, the plasma concentrations of ADMA in white coat hypertension (WCH) has not been previously studied. The aim of this study was to evaluate ADMA in WCH and compare with normotensive (NT) and hypertensive (HT) patients. We also evaluated the relation between ADMA and NO in these three groups. For this purpose, 34 NT, 34 white coat hypertensive (clinical hypertension and ambulatory daytime blood pressure <135/85 mmHg) and 34 HT patients were recruited in this study. The subjects were matched for age, gender, body mass index (BMI) and the patients with smoking habit, dyslipidaemia and diabetes mellitus were excluded. The ADMA levels were determined by high performance liquid chromatography. Plasma ADMA levels were significantly higher in WCH group than in the NT group (3.21+/-0.49 micromol/l vs 2.84+/-0.58 micromol/l, P=0.046). It was significantly higher in the HT group than in the NTs (4.24+/-0.38 micromol/l, P<0.001). There was also a significant difference between the HT and WCH groups (P<0.001). The WCH subjects had significantly higher levels of NO than the HTs (41.68+/-2.23 vs 32.18+/-2.68 micromol/l; P<0.001) and significantly lower values than the NTs (48.24+/-4.29 micromol/l; P<0.001). In WCH and HT group, there was a negative correlation between ADMA and NO (r=-0.515, P=0.003 and r=-0.389, P=0.034, respectively). In NT subjects, there was no correlation between these two parameters (r=-0.287, P=0.124). The correlation between ADMA and NO was stronger in WCH group than in HT group. Although NO levels in HT patients were lower than WCHs and ADMA levels were higher in HT patients than WCHs, the negative correlation of these two parameters were more pronounced in WCH group. Decreased NO and increased ADMA levels in WCH may indicate endothelial dysfunction. Our data indicate also that WCH represent an intermediate group between NT and HT when endothelial dysfunction is concerned.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829997     DOI: 10.1038/sj.jhh.1001867

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

Review 1.  Closer look at white-coat hypertension.

Authors:  Nurver Turfaner Sipahioglu; Fikret Sipahioglu
Journal:  World J Methodol       Date:  2014-09-26

Review 2.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

3.  Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population.

Authors:  Yangxi Huang; Yufeng Lin; Xiaobing Zhai; Long Cheng
Journal:  Front Cardiovasc Med       Date:  2022-05-13

4.  Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.

Authors:  S Yavuzer; H Yavuzer; M Cengiz; H Erman; M R Altıparmak; B Korkmazer; H Balci; G Simsek; A L Yaldıran; Y Karter; H Uzun
Journal:  J Hum Hypertens       Date:  2014-07-10       Impact factor: 3.012

5.  Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.

Authors:  Xinli Hu; Xin Xu; Guangshuo Zhu; Dorothee Atzler; Masumi Kimoto; Ju Chen; Edzard Schwedhelm; Nicole Lüneburg; Rainer H Böger; Ping Zhang; Yingjie Chen
Journal:  Circulation       Date:  2009-11-16       Impact factor: 29.690

Review 6.  White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.

Authors:  Yuli Huang; Weijun Huang; Weiyi Mai; Xiaoyan Cai; Dongqi An; Zhuheng Liu; He Huang; Jianping Zeng; Yunzhao Hu; Dingli Xu
Journal:  J Hypertens       Date:  2017-04       Impact factor: 4.844

7.  Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Areti Triantafyllou; Barbara Nikolaidou; Panagiota Anyfanti; Nikolaos Koletsos; Anastasios Vamvakis; Konstantina Dipla; Antonios Lazaridis; Stella Douma
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.